机译:Neoadjuvant重组人内皮抑素,多西紫杉醇和同性素的随机阶段III试验作为乳腺癌患者的一线治疗(CBCRT CBCRT 01)
Department of Thyroid Breast and Vascular SurgeryXijing Hospital Fourth Military Medical;
Department of Thyroid Breast and Vascular SurgeryXijing Hospital Fourth Military Medical;
Department of Thyroid Breast and Vascular SurgeryXijing Hospital Fourth Military Medical;
Department of EpidemiologyFourth Military Medical UniversityXi'an China;
Department of Thyroid Breast and Vascular SurgeryXijing Hospital Fourth Military Medical;
Department of Thyroid Breast and Vascular SurgeryXijing Hospital Fourth Military Medical;
Department of UltrasoundXijing Hospital Fourth Military Medical UniversityXi'an China;
Department of UltrasoundXijing Hospital Fourth Military Medical UniversityXi'an China;
Department of RadiologyXijing Hospital Fourth Military Medical UniversityXi'an China;
Department of UltrasoundXijing Hospital Fourth Military Medical UniversityXi'an China;
Department of Nuclear MedicineXijing Hospital Fourth Military Medical UniversityXi'an China;
Department of Thyroid Breast and Vascular SurgeryXijing Hospital Fourth Military Medical;
breast cancer; neoadjuvant chemotherapy; recombinant human endostatin (endostar); docetaxel; epirubicin;
机译:Neoadjuvant重组人内皮抑素,多西紫杉醇和同性素的随机阶段III试验作为乳腺癌患者的一线治疗(CBCRT CBCRT 01)
机译:4BA一项随机III期研究,比较了表柔比星,多西紫杉醇和卡培他滨(EDC)与表柔比星和多西紫杉醇(ED)作为早期乳腺癌的新辅助治疗-奥地利乳腺癌和结直肠癌研究组第24次试验(ABCSG-24)的初步结果
机译:将重组人内皮素的随机平行控制的第二阶段试验添加到III阶段乳腺癌的Neoadjuvant化疗中
机译:卟啉(Lu-Tex)对局部复发性乳腺癌患者的光动力治疗试验
机译:通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理:随机对照试验
机译:新辅助的rh-内皮抑素多西他赛和表柔比星治疗乳腺癌:一项前瞻性随机II期研究的有效性和安全性
机译:Neoadjuvant重组人内皮抑素,多西紫杉醇和同性素的随机阶段III试验作为乳腺癌患者的一线治疗(CBCRT01)
机译:I / II期研究联合新辅助激素治疗和每周OGX-011(Clusterin反义寡核苷酸)前局部前列腺癌根治性前列腺切除术